scispace - formally typeset
J

J A Fantl

Researcher at VCU Medical Center

Publications -  15
Citations -  3766

J A Fantl is an academic researcher from VCU Medical Center. The author has contributed to research in topics: Urinary incontinence & Menopause. The author has an hindex of 15, co-authored 15 publications receiving 3608 citations.

Papers
More filters
Journal ArticleDOI

Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group.

TL;DR: The short form versions of the Incontinence Impact Questionnaire (IIQ) and the Urogenital Distress Inventory (UDI) may be more useful than the long form versions in many clinical and research applications.
Journal ArticleDOI

Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group.

TL;DR: The current paper presents data on two new condition-specific instruments designed to assess the HRQOL of UI in women: the Urogenital Distress Inventory (UDI) and the Incontinence Impact Questionaire (IIQ).
Journal Article

Psychosocial impact of urinary incontinence in women.

TL;DR: The results in this study population indicate that the relationships between the perceived impact of incontinence and objective measures of its severity are complex and not directly proportionate.
Journal Article

Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee.

TL;DR: It appears that estrogen subjectively improves urinary incontinence in postmenopausal women, although the studies included nonhomogeneous groups, and the diagnostic criteria, therapeutic interventions, and outcome assessments varied considerably.
Journal ArticleDOI

Efficacy of estrogen supplementation in the treatment of urinary incontinence

TL;DR: Three-month cyclic hormone replacement therapy did not affect either clinical or quality of life variables of incontinent, hypoestrogenic women.